SCHEMBL1829972

SCHEMBL1829972

C1=CNCNCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6356002 0.92
SCHEMBL11866314 0.83
SCHEMBL11866309 0.83
SCHEMBL5592529 0.78
SCHEMBL29245137 0.78
SCHEMBL13860717 0.77
SCHEMBL121600 0.75
SCHEMBL27859696 0.75
Piperazine SCHEMBL3229382 0.75
SCHEMBL17244 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2318363-A1 HETEROCYCLIC DERIVATIVES AS IAP BINDING COMPOUNDS Nuevolution A/S (DK) 2011-05-11 EP claimed
WO-2009152824-A1 HETEROCYCLIC DERIVATIVES AS IAP BINDING COMPOUNDS NUEVOLUTION A/S (DK) 2009-12-23 WO claimed
US-20050143517-A1 Compositions consisting of cationic polymers comprising amidinium groups and ionic liquids CREAVIS GESELLSCHAFT F. TECHN. U. INNOVATION MBH (DE) 2005-06-30 US claimed
US-20260008777-A1 INHIBITORS OF PROTEIN TYROSINE PHOSPHATASE, COMPOSITIONS, AND METHODS OF USE BRISTOL-MYERS SQUIBB COMPANY (US) 2026-01-08 US disclosed
EP-3135681-B1 RUTHENIUM COMPLEX, METHOD FOR PRODUCING SAME, AND USE OF SAME TAKASAGO PERFUMERY CO LTD (JP) 2020-08-19 EP disclosed
EP-2952503-B1 CARBOXYLIC ACID DERIVATIVES AS HIV REPLICATION INHIBITOR SHIONOGI & CO (JP) 2019-10-23 EP disclosed
CN-110062796-A Hardenable polymer composition 巴斯夫欧洲公司 2019-07-26 CN disclosed
CN-109071446-A The organic reaction carried out in aqueous solution in the presence of hydroxy alkyl (alkyl) cellulose or alkylcellulose 艾伯维德国有限责任两合公司 2018-12-21 CN disclosed
US-10059729-B2 Ruthenium complex, method for producing same, and use of same TAKASAGO INTERNATIONAL CORPORATION (JP) 2018-08-28 US disclosed
EP-3135681-A1 RUTHENIUM COMPLEX, METHOD FOR PRODUCING SAME, AND USE OF SAME Takasago International Corporation (JP) 2017-03-01 EP disclosed
US-20170044196-A1 RUTHENIUM COMPLEX, METHOD FOR PRODUCING SAME, AND USE OF SAME TAKASAGO INTERNATIONAL CORPORATION (JP) 2017-02-16 US disclosed
WO-2010107605-A1 CGRP RECEPTOR ANTAGONISTS MERCK SHARP & DOHME CORP. (US) 2010-09-23 WO disclosed
WO-2010021919-A1 3- AND 6-QUINOLINES WITH N-ATTACHED HETEROCYCLIC CGRP RECEPTOR ANTAGONISTS MERCK SHARP & DOHME CORP. (US) 2010-02-25 WO disclosed
WO-2009152824-A1 HETEROCYCLIC DERIVATIVES AS IAP BINDING COMPOUNDS NUEVOLUTION A/S (DK) 2009-12-23 WO disclosed
US-20050143517-A1 Compositions consisting of cationic polymers comprising amidinium groups and ionic liquids CREAVIS GESELLSCHAFT F. TECHN. U. INNOVATION MBH (DE) 2005-06-30 US disclosed
US-20050119431-A1 Novel cationic polymers containing amidinium groups and their use DEGUSSA AG (DE) 2005-06-02 US disclosed
US-4102890-A HYPNOTIC, ANALGESIC, HYPOTENSIVE, CARDIOVASCULAR DEPRESSANTS, NEURO-MODULATORS SCIENCE-UNION ET CIE, SOCIETE FRANCAISE DE RECHERCHE MEDICALE (FR) 1978-07-25 US disclosed
US-3996207-A Derivatives of tetrahydro-1H-1,3-diazepine and hexahydro-1,3-diazocine JOHN WYETH & BROTHER LIMITED (EN) 1976-12-07 US disclosed
US-3996207-A Derivatives of tetrahydro-1H-1,3-diazepine and hexahydro-1,3-diazocine JOHN WYETH & BROTHER LIMITED (EN) 1976-12-07 US disclosed
US-3926994-A Heterocyclic compounds WYETH JOHN & BROTHER LTD 1975-12-16 US disclosed